ExecuPharm, with a core management team with extensive clinical operations experience, understands clinical trial challenges and how to solve clinical outsourcing, staffing, placement, technology and process needs. ExecuPharm's distinctive business model incorporates flexible models of service and technologies to support every aspect of a clinical trial. Through our continual investment in the development of our state of the art services from cutting edge biomarker and companion diagnostics through to step changes in the management of the clinical trial data and the clinical supply chain to biocatalytic manufacture of API, Almac ensures they are always there to support you across the product development lifecycle.ĮxecuPharm is a Global Functional Service Contract Research Organization, certified by the Women's Business Enterprise National Council (WBENC), who provides clinical research support services for the pharmaceutical industry. Almac is headquartered in Craigavon, Northern Ireland with operations in the UK, Ireland, across the US (Pennsylvania, North Carolina and California) and in Asia (Singapore and Tokyo). They are a privately owned organisation that has organically grown over 40 years and now employs in excess of 4,500 highly skilled personnel. The services range from R&D, biomarker discovery and development, API manufacture, formulation development, clinical trial supply, IXRS technology (IVRS/IXRS) through to commercial-scale manufacture and companion diagnostic development.Only Almac can combine the expertise, from their specialised teams, to provide you with the right service solutions to help you across the full biopharmaceutical product lifecycle, from the preclinical stages through to commercialisation. The Almac Group is an established contract development and manufacturing organisation that provides an extensive range of integrated services globally to companies within the pharmaceutical and biotech sectors. The company was incorporated in 2004 and is based in Wayne, Pennsylvania. has distributors in Australia, Denmark, Finland, Hong Kong, Israel, Malaysia, Norway, Philippines, Singapore, South Africa, South Korea, and Thailand. It has sales and marketing infrastructure with a portfolio of products targeting the United States, Canada, the United Kingdom, France, Germany, Ireland, Italy, and Spain markets. The company markets its products to defined customer groups, such as specialist doctors. It also develops a range of treatments for ADHD to treat children, adolescents, and adults, as well as researches on non-scheduled compounds. The company offers ADDERALL and ADDERALL XR for attention deficit hyperactivity disorder (ADHD) REMINYL for Alzheimer's and CARBATROL for epilepsy. It focuses on central nervous system, gastrointestinal, general products, renal diseases, and human genetic therapies. develops, manufactures, markets, and sells pharmaceutical products. ![]() ![]() With a sterile manufacturing facility located in Rochester, Michigan, Par Sterile Products possesses an unparalleled reputation for high-quality products and an impeccable record of regulatory compliance.Shire Pharmaceuticals, Inc. Par Sterile Products develops, manufactures and markets a broad portfolio of branded and generic aseptic injectable products. Our focus is on therapeutically equivalent ANDA-based products, and others on a case-by-case basis. Par Pharmaceutical specializes in modified-released oral solid dosage forms as well as non-oral dosage forms, such as nasal sprays, inhalers, patches and other alternative drug delivery platforms. We offer high-quality, cost-effective products with the highest level of customer service. Par Pharmaceutical, a wholly owned Endo business, is a highly focused generic pharmaceutical company dedicated to delivering quality medicines to patients in need through excellence in innovation, development, manufacturing, and commercialization.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |